Recipient interleukin-1β production is critical for lung allograft acceptance

Area of Science:

• Immunology
• Transplantation Biology
• Pulmonary Medicine

Background:

• Proinflammatory cytokines like IL-1β, TNF-α, and IL-6 are linked to solid organ transplant rejection.
• Mechanisms of lung transplant rejection and tolerance are not fully understood.
• Existing protocols often target these cytokines to prevent rejection.

Purpose of the Study:

• To investigate the role of inflammatory cytokines in lung allograft acceptance using a mouse model.
• To elucidate the specific functions of IL-1β in the context of lung transplantation.
• To determine if recipient IL-1β is essential for preventing acute lung allograft rejection.

Main Methods:

• Utilized a mouse lung transplantation model.
• Analyzed cytokine profiles and immune cell infiltration in allografts.
• Assessed the expression of inducible nitric oxide synthase (iNOS) in neutrophils.
• Investigated the impact of IL-1β deficiency on allograft survival and function.
• Examined neutrophil-mediated T cell suppression in vitro.

Main Results:

• Recipient IL-1β induced granulocyte colony-stimulating factor release and neutrophil infiltration into lung allografts.
• Neutrophils expressed immunosuppressive gene signatures and promoted nitric oxide (NO) accumulation via iNOS.
• NO-dependent neutrophil activity was critical for lung allograft acceptance.
• IL-1β-deficient recipients experienced acute lung allograft rejection, unlike wild-type recipients.

Conclusions:

• Recipient IL-1β plays a critical, previously unrecognized role in promoting lung allograft acceptance.
• This contrasts with the traditional view of pro-inflammatory cytokines exacerbating transplant outcomes.
• Findings suggest IL-1β is a key mediator of pulmonary tolerance and informs lung-specific immunosuppressive strategies.